Introduction Glaucoma is one of the leading causes of blindness worldwide, and approximately 79.6 million people have glaucoma today, with a positive trend, the prevalence is expected to increase to 111.8 million in 2040 [ 1 , 2 ].
← all excerpts
The Effect of Prostaglandin F2 Analog Treatment on the Immunoexpression of Fibrosis-Associated Factors in Patients with Glaucoma Undergoing Deep Sclerotomy.
1
—
—